- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Mapping global public perspectives on mRNA vaccines and therapeutics ; volume:9 ; number:1 ; day:14 ; month:11 ; year:2024 ; pages:1-12 ; date:12.2024
npj vaccines ; 9, Heft 1 (14.11.2024), 1-12, 12.2024
- Urheber
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41541-024-01019-3
- URN
-
urn:nbn:de:101:1-2502040930278.059066432440
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:30 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Xu, Jiaxiang
- Wu, Zhengdong
- Wass, Lily
- Larson, Heidi
- Lin, Leesa
- SpringerLink (Online service)
Ähnliche Objekte (12)
Current perspectives on vaccines and therapeutics for Lassa Fever
The potential use of therapeutics and prophylactic mRNA vaccines in human papillomavirus (HPV)
Immunogenicity of lipid nanoparticles and its impact on the efficacy of mRNA vaccines and therapeutics
Intellectual property issues : therapeutics, vaccines and molecular diagnostics
mRNA vaccines: A lucky shot?
Ricin and Shiga toxins : pathogenesis, immunity, vaccines and therapeutics
Zika vaccines and therapeutics: landscape analysis and challenges ahead
Chemically modified mRNA Therapeutics for Bone Regeneration
Cancer vaccines as promising immuno-therapeutics: platforms and current progress
mRNA vaccines in disease prevention and treatment
The advances of adjuvants in mRNA vaccines
A Comprehensive Review of COVID-19 Virology, Vaccines, Variants, and Therapeutics
Current perspectives on vaccines and therapeutics for Lassa Fever
The potential use of therapeutics and prophylactic mRNA vaccines in human papillomavirus (HPV)
Immunogenicity of lipid nanoparticles and its impact on the efficacy of mRNA vaccines and therapeutics
Intellectual property issues : therapeutics, vaccines and molecular diagnostics
mRNA vaccines: A lucky shot?
Ricin and Shiga toxins : pathogenesis, immunity, vaccines and therapeutics
Zika vaccines and therapeutics: landscape analysis and challenges ahead
Chemically modified mRNA Therapeutics for Bone Regeneration
Cancer vaccines as promising immuno-therapeutics: platforms and current progress
mRNA vaccines in disease prevention and treatment
The advances of adjuvants in mRNA vaccines
A Comprehensive Review of COVID-19 Virology, Vaccines, Variants, and Therapeutics
Current perspectives on vaccines and therapeutics for Lassa Fever
The potential use of therapeutics and prophylactic mRNA vaccines in human papillomavirus (HPV)
Immunogenicity of lipid nanoparticles and its impact on the efficacy of mRNA vaccines and therapeutics
Intellectual property issues : therapeutics, vaccines and molecular diagnostics
mRNA vaccines: A lucky shot?
Ricin and Shiga toxins : pathogenesis, immunity, vaccines and therapeutics
Zika vaccines and therapeutics: landscape analysis and challenges ahead
Chemically modified mRNA Therapeutics for Bone Regeneration
Cancer vaccines as promising immuno-therapeutics: platforms and current progress
mRNA vaccines in disease prevention and treatment
The advances of adjuvants in mRNA vaccines